You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Covid-19: $30 bn needed to develop tests, treatments, vaccines, says WHO

The WHO is working with a large coalition of drug-development, funding and distribution organisations under what it calls the ACT-Accelerator Hub

Topics
Coronavirus | Coronavirus Vaccine | World Health Organisation

Reuters 

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
The initiative is intended to develop and deliver 500 million Covid-19 tests and 245 million courses of new treatment for the disease

A World Health Organization-led coalition fighting the Covid-19 pandemic is asking government and private sector donors to help raise $31.3 billion in the next 12 months to develop and deliver tests, treatments and vaccines for the disease.

Renewing its call on Friday for global collaboration against the pandemic, it said $3.4 billion had been contributed for the coalition to date, leaving a funding gap of $27.9 billion. Of that, $13.7 billion was "urgently needed".

ALSO READ: After Hindustan Unilever, L'Oreal to drop 'white' from skin care range

The WHO is working with a large coalition of drug-development, funding and distribution organisations under what it calls the ACT-Accelerator Hub.

The initiative is intended to develop and deliver 500 million Covid-19 tests and 245 million courses of new treatment for the disease to low- and middle-income countries by mid-2021, it said in a statement.

It also hoping 2 billion vaccines doses, including 1 billion to be bought by low- and middle-income countries, will be available by the end of 2021.

ALSO READ: Coronavirus LIVE: India cases top 500,000; Goa CM hints at community spread

The ACT-Accelerator was launched in April to speed up research and development work on medical tools to tackle Covid-19. On Friday, the WHO said the pandemic was still threatening millions of lives and scores of economies, and urgent work and funds were needed.

"The investment required is significant, but it pales in significance when compared to the cost of Covid-19," it said.

First Published: Sat, June 27 2020. 01:59 IST
RECOMMENDED FOR YOU